Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Check out some of our latest original content that was created and distributed as part of our ongoing collaborations with IR firms and other companies.

New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Is ‘One to Watch’

Posted on June 25, 2025 by MissionIR
  • New Pacific Metals owns two of the largest undeveloped open-pit silver projects globally, offering substantial resource potential and long-term production growth.
  • The company’s projects demonstrate strong economic fundamentals, with high internal rates of return and low all-in sustaining costs per ounce of silver.
  • Bolivia’s underexplored mineral potential presents a strategic advantage for New Pacific Metals, allowing it to capitalize on a historically rich mining region.
  • The company is backed by two strategic shareholders: Silvercorp Metals (28%) and Pan American Silver (12%).
  • The company is supported by an experienced leadership team with a track record of success in mineral exploration, development, and corporate finance.
  • As global silver demand increases for industrial and renewable energy applications, New Pacific Metals is well-positioned to benefit from market growth and rising silver prices.

New Pacific Metals (NYSE American: NEWP) (TSX: NUAG) is a Canadian exploration and development company focused on advancing world-class silver projects in Bolivia. The company’s primary asset, the Silver Sand project, has the potential to become one of the largest silver mines globally, supported by robust economic assessments. Additionally, the company is progressing its Carangas project, a silver-lead-zinc deposit with scale.

New Pacific Metals aims to create long-term value for its shareholders by advancing and de-risking its quality silver assets while contributing to the economic growth of Bolivia.

New Pacific Metals is headquartered in Vancouver, British Columbia, Canada.

Projects

Silver Sand Project

The flagship Silver Sand project is a high-grade silver deposit with an expected mine life of 13 years. A preliminary feasibility study (“PFS”) completed in June 2024 estimates an annual production of 12 million ounces of silver, including 15 million ounces in the first three years of operation, with total projected production reaching 157 million ounces. The project has a post-tax net present value (“NPV5%”) of $740 million at a silver price of $24 per ounce and an internal rate of return (“IRR”) of 37%. With a low all-in sustaining cost (“AISC”) of $10.69 per ounce and a 1.9-year payback period, Silver Sand presents a rare and compelling silver opportunity.

Carangas Project

The Carangas project is an emerging silver-lead-zinc deposit with a 16-year mine life. A preliminary economic assessment (“PEA”) completed in September 2024 indicates an annual production of 6.6 million ounces of silver, with total production projected at 106 million ounces. The project boasts an after-tax NPV5% of $501 million, an IRR of 26%, and a payback period of 3.2 years at $24 per ounce silver. Its low AISC of $7.60 per ounce positions Carangas as a high-margin operation with significant upside potential. The PEA preserves Carangas’ significant gold (1+ million ounces) potential at depth.

Market Opportunity

The global silver market continues to see increasing demand driven by industrial applications, investment interest, and the growing use of silver in renewable energy technologies. Bolivia, ranked as the fourth-largest silver-producing country, presents significant untapped potential due to limited modern exploration.

The Silver Sand and Carangas projects represent two of the largest undeveloped open-pit silver projects in the world, with the potential to deliver substantial production volumes. As silver prices remain favorable and demand continues to rise, New Pacific Metals is positioned to play a crucial role in supplying the global silver market.

Leadership Team

Dr. Rui Feng, Founder, is a geologist and entrepreneur with over 25 years of experience in mineral exploration and project development. In 2003, Dr. Feng founded Silvercorp, acquiring early-stage properties in China. Through discovery and development, Silvercorp has become one of the most profitable Canadian mining companies, with multiple mines in China. Building on that success, Dr. Feng established New Pacific Metals, where he has been instrumental in the discovery and advancement of its key projects. With a track record of building successful mining ventures, he continues to provide strategic insight to the company’s growth initiatives.

Jalen Yuan, Interim CEO, is a corporate leader and professional accountant with over sixteen years of diverse international experience in the mining industry.  Mr. Yuan has been deeply involved in all of the company’s strategic decisions as Chief Financial Officer since 2015, including those related to the acquisition, exploration, technical studies, and permitting of the Silver Sand and Carangas projects in Bolivia, prior to his appointment as Interim Chief Executive Officer in April 2025. Mr. Yuan also played instrumental roles in the company’s financing activities, raising a total of US$130 million since 2017.

Dickson Hall, Chairman of the Board of Directors, has over 40 years of experience in finance and corporate development, with a strong emphasis on the mining sector. He is a Partner at Valuestone Advisors Limited, sole advisor of Valuestone Global Resource Fund 1, and a director of Bunker Hill Mining Corp. and MEC Advisors Limited. Fluent in Mandarin and well-experienced in Chinese business culture, Mr. Hall has worked with an extensive group of multinationals, trade associations, and government organizations with China operations. He is a graduate of the University of British Columbia.

For more information, visit the company’s website at www.NewPacificMetals.com.

NOTE TO INVESTORS: The latest news and updates relating to NEWP are available in the company’s newsroom at https://ibn.fm/NEWP

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
[email protected]

MissionIR is powered by IBN

Posted in New Pacific Metals Corp. NEWP | Leave a comment

MissionIRNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Expands Fingerprint Drug Testing Across Scandinavia with Spjotgard Partnership

Posted on June 25, 2025 by MissionIR

Intelligent Bio Solutions (NASDAQ: INBS), a medical technology firm specializing in non-invasive drug screening, reported continued success in its partnership with Spjotgard, a Scandinavian distributor. The collaboration is accelerating adoption of INBS’ fingerprint-based Drug Screening System across Sweden, Norway, and Denmark, with Finland showing rising interest. The technology offers a less invasive, hygienic alternative to urine and saliva tests, delivering results in under 10 minutes and gaining traction in sectors like logistics, education, and criminal justice. Spjotgard’s growing regional presence and strategic alliances position INBS to scale further in Northern Europe.

To view the full article, visit https://ibn.fm/PJPCa

About Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company’s current customer segments outside the US include construction, manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners.

NOTE TO INVESTORS: The latest news and updates relating to INBS are available in the company’s newsroom at https://ibn.fm/INBS

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
[email protected]

MissionIR is powered by IBN

Posted in Intelligent Bio Solutions Inc. INBS | Leave a comment

D-Wave Quantum Inc. (NYSE: QBTS) Partners with Yonsei University and Incheon City to Advance Quantum Adoption in South Korea

Posted on June 24, 2025 by MissionIR
  • The three parties signed an MOU focusing on research collaboration, education, and commercial use case development.
  • MOU facilitates the organizations’ efforts towards the acquisition of a D-Wave Advantage2(TM) system at the Yonsei University International Campus.
  • The collaboration aims to advance mutual research and talent development for quantum computing, provide access to D-Wave’s quantum computing technology, and explore the development of use cases in biotechnology, materials science and other areas.

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, has entered into a strategic partnership with Yonsei University and Incheon Metropolitan City designed to accelerate quantum computing adoption and commercialization in South Korea. The company announced the signing of a memorandum of understanding (“MOU”) on June 17, outlining plans for quantum computing research, education, and collaboration (https://ibn.fm/0NaSv).

A central aim of the initiative is to facilitate the acquisition of a D-Wave Advantage2 system at Yonsei University’s International Campus in Songdo, Incheon. Installing such a system in South Korea would mark a step forward in the region’s broader quantum infrastructure ambitions. Under the terms of the MOU, the parties plan to also explore quantum computing’s potential use cases in sectors such as biotechnology and materials science. 

The partnership follows the recent announcement of general availability of the Advantage2 quantum computing system, which marked the release of what the company calls its most performant system yet, delivering energy-efficient, scalable quantum processing capable of tackling some problems that are beyond the capabilities of classical computing. The system features more than 4,400 qubits and is available through D-Wave’s Leap(TM) real-time quantum cloud service and for on-premises deployment by enterprises and research institutions.

“This collaboration with D-Wave and Incheon Metropolitan City supports our mission to facilitate a collaborative ecosystem for quantum computing literacy, research and commercial application development,” said Dong-Sup Yoon, president of Yonsei University. Yoon added that having a D-Wave annealing quantum computer onsite would offer “significant opportunities to advance industry and research in South Korea.”

For Incheon Metropolitan City, the MOU aligns with broader ambitions to become a global technology hub. “We have a unique opportunity to establish Incheon as a global quantum hub,” said Mayor Yoo Jeong-bok, citing the region’s established strengths in the bio industry and its potential to attract global quantum talent. “Building on Incheon’s strengths in the bio industry and other key sectors, we anticipate the emergence of a true quantum cluster where quantum technology converges with various industries to create innovative breakthroughs and attract top talent from around the world,” the mayor added.

According to Dr. Alan Baratz, CEO of D-Wave, the initiative represents both a regional and international milestone. “This strategic relationship marks an important step in furthering D-Wave’s mission to accelerate global quantum computing adoption,” said Dr. Baratz. “Yonsei University and Incheon Metropolitan City recognize the remarkable, immediate opportunity for scientific breakthroughs and business transformation possible with D-Wave’s quantum computing technology. We look forward to the possibility of installing a system at Yonsei University to further establish its role as a global quantum hub.”

About D-Wave Quantum Inc.

D-Wave is a leader in the development and delivery of quantum computing systems, software, and services. We are the world’s first commercial supplier of quantum computers, and the only company building both annealing and gate-model quantum computers. Our mission is to help customers realize the value of quantum, today. Our quantum computers, the world’s largest, are available on-premises or via the cloud, supported by 99.9% availability and uptime. More than 100 organizations trust D-Wave with their toughest computational challenges. With over 200 million problems submitted to our quantum systems to date, our customers apply our technology to address use cases spanning optimization, artificial intelligence, research and more. Learn more about realizing the value of quantum computing today and how we’re shaping the quantum-driven industrial and societal advancements of tomorrow: www.dwavequantum.com.

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

Forward Looking Statements

Certain statements in this press release are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including the risks set forth under the heading “Risk Factors” discussed under the caption “Item 1A. Risk Factors” in Part I of our most recent Annual Report on Form 10-K or any updates discussed under the caption “Item 1A. Risk Factors” in Part II of our Quarterly Reports on Form 10-Q and in our other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this press release in making an investment decision, which are based on information available to us on the date hereof. We undertake no duty to update this information unless required by law.

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
[email protected]

MissionIR is powered by IBN

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Taps IBN to Lead Corporate Communications Amid Drug Advancements and Subsidiary Launch

Posted on June 24, 2025 by MissionIR

NRx Pharmaceuticals (NASDAQ: NRXP) a clinical-stage biopharmaceutical company developing innovative treatments for suicidal depression and PTSD, has engaged IBN to manage its corporate communications strategy. NRx is advancing two FDA-designated therapies—NRX-100 and NRX-101—with an NDA underway for NRX-100 and additional regulatory filings in progress. The company also launched HOPE Therapeutics, a subsidiary focused on building a national psychiatric care network, with plans for a public spin-out. IBN will leverage its extensive media portfolio to expand investor awareness and outreach.

To view the full press release, visit https://ibn.fm/L8kUd

About NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRx plans to file an NDA for Accelerated Approval for NRX-101 in patients with bipolar depression and suicidality or akathisia. NRX-101 additionally has potential to act as a non-opioid treatment for chronic pain, as well as a treatment for complicated UTI.

NRx has recently initiated a New Drug Application filing for NRX-100 (IV ketamine) for the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreement. NRx was awarded Fast Track Designation for development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality.

NOTE TO INVESTORS: The latest news and updates relating to NRXP are available in the company’s newsroom at https://ibn.fm/NRXP

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
[email protected]

MissionIR is powered by IBN

Posted in NRx Pharmaceuticals Inc. NRXP | Leave a comment

MissionIRNewsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Acquires Nautical Ventures to Launch First Integrated Electric Boat Dealership in North America

Posted on June 23, 2025 by MissionIR

Vision Marine Technologies (NASDAQ: VMAR), a leader in high-voltage electric marine propulsion, has acquired Nautical Ventures Group, a top U.S. boat dealership and 2024 Boating Industry “Dealer of the Year.” The move establishes North America’s first combined electric boat propulsion and dealership platform, pairing Vision Marine’s E-Motion(TM) powertrain with Nautical Ventures’ extensive retail network, inventory, and service capabilities.

With nine Florida locations and a portfolio that includes brands like Axopar, Yamaha, and Beneteau, Nautical Ventures provides Vision Marine direct access to one of the world’s most active boating markets. The acquisition adds direct-to-consumer capabilities, expanded revenue streams, and positions the company to scale nationwide. Funded through cash, a seller’s note, and stock, the deal was advised by ThinkEquity.

To view the full press release, visit https://ibn.fm/mXD9w

About Vision Marine Technologies Inc.
Vision Marine Technologies Inc. (NASDAQ: VMAR) is a leading innovator in high-voltage electric propulsion systems for the recreational marine industry. The Company’s E-Motion™ powertrain offers OEMs and consumers a scalable, zero-emission, high-performance alternative to internal combustion systems. Vision Marine’s mission is to transform the boating experience through technology, efficiency, and integrated end-to-end electric solutions. Visit:www.visionmarinetechnologies.com

NOTE TO INVESTORS: The latest news and updates relating to VMAR are available in the company’s newsroom at https://ibn.fm/VMAR

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
[email protected]

MissionIR is powered by IBN

Posted in Vision Marine Technologies Inc. VMAR | Leave a comment

Vivakor Inc. (NASDAQ: VIVK): A Modern Answer to Oil’s Dirty Problem

Posted on June 23, 2025 by MissionIR
  • Vivakor’s Q1 2025 revenue soared 133% year-over-year to $37.3 million
  • The company announced a special dividend to shareholders, distributing shares in Adapti Inc. as part of a non-cash value initiative
  • Vivakor specializes in sustainable energy transport, reuse, and remediation, critical as oil demand persists and environmental urgency rises

Despite growing investment in renewable energy, the world continues to run on oil and will for decades to come. From manufacturing solar panels to powering global transport, fossil fuels remain deeply embedded in every corner of industrial life. But as the environmental toll of this dependency grows harder to ignore, a middle path is gaining momentum: sustainably managing the dirty byproducts of oil while continuing to support energy demand. That’s exactly where Vivakor (NASDAQ: VIVK) has carved its niche; offering integrated solutions that transport, store, reuse, and remediate energy materials across the U.S.

A Record Start 

Vivakor kicked off the year with impressive momentum, reporting a 133% increase in revenue to $37.3 million for Q1 2025. Gross profit jumped 345% to $4.8 million, supported by a healthy gross margin of 12.7%. The lion’s share of revenue came from terminaling and storage services ($23.8 million), while transportation logistics, including related-party operations, contributed $13.5 million.

CEO James Ballengee attributed the performance to Vivakor’s strong long-term contracts and operational adjustments amid global uncertainties, including softening crude prices. “Our midstream assets—vehicles, trailers, pipelines, terminals—are contracted at the highest revenue levels in our company’s history,” said Ballengee. “We anticipate further expansion to support increasing demand.”

While Vivakor posted an operating loss of $6.4 million for the quarter, this figure included $8.2 million in non-cash expenses such as depreciation, amortization, and asset disposition. The company’s adjusted EBITDA turned positive, reaching $319,000 compared to a slight loss a year earlier.

Vivakor ended the quarter with $248.2 million in total assets and $108.8 million in stockholders’ equity, underscoring its growing footprint in the U.S. energy infrastructure landscape.

Sustainable Energy Services 

Vivakor doesn’t promise a fossil-free utopia; it offers tangible solutions to modern energy problems. Operating one of the largest oilfield trucking fleets in the continental U.S., the company plays a central role in safely moving, storing, and processing crude oil and oilfield waste. Its remediation facilities are built to recover, reuse, and dispose of petroleum byproducts with minimal environmental impact.

This model not only supports existing energy infrastructure but also provides a cleaner, more responsible way to manage oil’s lifecycle. As solar and wind buildouts accelerate, the irony remains: they rely on oil at nearly every stage, from raw material extraction to panel deployment. Until a true fossil fuel alternative emerges, companies like Vivakor that handle the “messy middle” will be critical players.

Creating Value Beyond the Core Business

In addition to its operational achievements, Vivakor also made headlines by announcing a special dividend for shareholders. The dividend consists of shares in Adapti Inc., a tech firm that leverages AI to match products with influencers through its AdaptAI platform.

Vivakor owns roughly 206,595 shares in Adapti (approximately 13.5% of its outstanding common stock) and will distribute a portion of that equity to shareholders, excluding shares held by Vivakor executives who have waived their right to participate. Based on current valuations, the dividend is worth approximately $0.815 million.

This move not only rewards investors but highlights Vivakor’s non-traditional approach to value creation, using owned equity stakes in outside ventures as an asset strategy.

Positioned for a New Era of Energy Accountability

The energy transition isn’t just about replacing oil. It’s about managing its risks, cleaning up its footprint, and building systems that are both scalable and sustainable. Vivakor’s end-to-end platform fits neatly into this reality, offering a responsible solution in a world that still runs on hydrocarbons.

From rising revenues to shareholder-friendly policies, Vivakor is proving that cleaner energy services and solid business performance don’t have to be mutually exclusive. And as 2025 unfolds, the company looks well-positioned to continue growing its reach, while helping the oil-driven world we inherited operate more sustainably.

For more information, visit the company’s website at Vivakor.com.

NOTE TO INVESTORS: The latest news and updates relating to VIVK are available in the company’s newsroom at https://ibn.fm/VIVK

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
[email protected]

MissionIR is powered by IBN

Posted in Vivakor Inc. VIVK | Leave a comment

MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Applies for FDA Commissioner’s Priority Voucher for NRX-100 Ketamine Formulation

Posted on June 23, 2025 by MissionIR

NRx Pharmaceuticals (NASDAQ: NRXP) has filed for the newly launched FDA Commissioner’s National Priority Voucher (CNPV) program, seeking accelerated review for NRX-100, its preservative-free intravenous ketamine formulation. The company believes NRX-100 meets all criteria outlined by FDA Commissioner Marty Makary, who announced the voucher program on June 17, 2025, to prioritize treatments aligned with urgent U.S. health needs—including suicidal depression and PTSD.

NRx has already submitted the chemistry, manufacturing, and controls (CMC) portion of its application and received FDA feedback, placing it on track for potential accelerated review of its full New Drug Application (NDA) by late 2025. If granted, the voucher would cut review times to 1–2 months versus the standard 10–12 months. Concurrently, NRx is advancing a citizen petition to withdraw preservative-containing ketamine products and has filed a patent for its preservative-free manufacturing process, aiming to capture share in a ketamine market projected to reach up to $5 billion annually by 2033.To view the full press release, visit https://ibn.fm/YNhvT

About NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRx plans to file an NDA for Accelerated Approval for NRX-101 in patients with bipolar depression and suicidality or akathisia. NRX-101 additionally has potential to act as a non-opioid treatment for chronic pain, as well as a treatment for complicated UTI.

NRx has recently initiated a New Drug Application filing for NRX-100 (IV ketamine) for the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreement. NRx was awarded Fast Track Designation for development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality.

NOTE TO INVESTORS: The latest news and updates relating to NRXP are available in the company’s newsroom at https://ibn.fm/NRXP

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
[email protected]

MissionIR is powered by IBN

Posted in NRx Pharmaceuticals Inc. NRXP | Leave a comment

MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Price Target Raised to $15 Following AVERSA Fentanyl Manufacturing Milestone

Posted on June 23, 2025 by MissionIR

Nutriband (NASDAQ: NTRB) has received a new $15 price target in an updated report from Robert LeBoyer, Senior Vice President and Equity Research Analyst, Biotechnology, at Noble Capital Markets, following the successful completion of commercial manufacturing and scale-up for AVERSA Fentanyl, its abuse-deterrent transdermal patch developed in partnership with Kindeva.

The report highlights this milestone as a key inflection point that enables Nutriband to initiate production of clinical supplies and proceed with its planned Investigational New Drug (“IND”) application for a Phase 1 trial. The AVERSA program follows the 505(b)(2) regulatory pathway and requires only a single Phase 1 study, aimed at showing reduced appeal to recreational drug users—a step the analyst views as low risk.

LeBoyer raised his FY2027 EPS forecast to $1.57, citing Nutriband’s adherence to timeline projections and avoidance of a previously expected Q1 2025 equity raise. Full-year sales are projected to begin in FY2027, with the NDA submission expected between late 2025 and early 2026.

To view the full report, visit https://ibn.fm/IWkz5

About Nutriband Inc.

Nutriband is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Its lead product under development is an abuse-deterrent fentanyl patch incorporating its AVERSA(TM) abuse-deterrent technology. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential. For more information about the company, visit www.Nutriband.com.

NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company’s newsroom at https://ibn.fm/NTRB

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
[email protected]

MissionIR is powered by IBN

Posted in Nutriband Inc. NTRB | Leave a comment

MissionIRNewsBreaks – Why Silvercorp Metals Inc. (NYSE American: SVM) (TSX: SVM) Is ‘One to Watch’

Posted on June 20, 2025 by MissionIR

Silvercorp Metals (NYSE American: SVM) (TSX: SVM) is a Canadian mining company with a strong track record of profitability, managing a broad portfolio of producing mines, development-stage projects, and exploration assets across China, Ecuador, and Bolivia. The company is committed to maximizing output from its existing operations while strategically advancing new projects to support long-term growth. As noted in a recent article, Silvercorp’s diversified asset base provides both steady cash-flow from current operations and exposure to high-potential projects, positioning the company to deliver lasting value for shareholders.

To view the full article, visit https://ibn.fm/yiUfw

About Silvercorp Metals Inc.

Silvercorp is a Canadian mining company producing silver, gold, lead, and zinc with a long history of profitability and growth potential. The company’s strategy is to create shareholder value by 1) focusing on generating free cash flow from long life mines; 2) organic growth through extensive drilling for discovery; 3) ongoing merger and acquisition efforts to unlock value; and 4) long term commitment to responsible mining and ESG. For more information, visit the company’s website at www.SilverCorpMetals.com.

NOTE TO INVESTORS: The latest news and updates relating to SVM are available in the company’s newsroom at https://ibn.fm/SVM

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
[email protected]

MissionIR is powered by IBN

Posted in Silvercorp Metals Inc. SVM | Leave a comment

Nutriband Inc. (NASDAQ: NTRB) Reimagining Drug Safety Through Scalable Innovation

Posted on June 20, 2025 by MissionIR
  • Nutriband Inc. has been granted a new U.S. patent for its AVERSA(TM) transdermal abuse-deterrent technology, expanding its domestic IP coverage
  • AVERSA(TM) is designed to prevent misuse, abuse, and accidental exposure of transdermal drugs with abuse potential, such as fentanyl
  • With overdose deaths still plaguing the U.S., Nutriband’s platform has the potential to enhance drug safety across multiple therapeutic categories

The opioid crisis remains one of the most persistent public health emergencies in the U.S. While state and federal initiatives have helped curb some of the worst-case trajectories, more than 100,000 Americans still die each year from drug overdoses, a significant proportion linked to synthetic opioids like fentanyl. The crisis is evolving, not disappearing, and the pharmaceutical industry continues to grapple with the challenge of balancing patient access with the need for safety and deterrence.

A key piece of the solution may lie not just in prescribing practices, but in the very design of the drug delivery systems themselves. That’s where companies like Nutriband (NASDAQ: NTRB) are stepping in with novel technologies that aim to prevent abuse at the product level. Recent developments, including a new patent granted by the U.S. Patent and Trademark Office, show the company is doubling down on intellectual property protection as it pushes toward commercialization of its flagship solution.

Understanding the Role of Fentanyl Patches

Fentanyl patches are commonly prescribed for chronic, severe pain in opioid-tolerant patients, such as those with cancer or advanced neurological conditions. They deliver medication steadily over 72 hours, offering consistent relief and better adherence for long-term pain management.

Because fentanyl is 50–100 times stronger than morphine, the patches are not used for short-term or acute pain and carry serious risks, including respiratory depression and overdose, especially in opioid-naïve individuals.

Due to their potency, fentanyl patches are often misused through extraction and abuse, prompting regulatory scrutiny and the need for safer design. Nutriband’s Aversa technology addresses this by incorporating deterrents directly into the patch, helping prevent misuse while preserving therapeutic value. The Aversa platform incorporates extremely sour and incredibly spicy aversive agents into standard drug patches, to prevent tampering, misuse, and accidental exposure, without sacrificing therapeutic benefits for patients who genuinely need these medications.

A New Layer of Protection for Transdermal Drug Delivery

On June 3, 2025, the USPTO granted Patent No. 12,318,492 titled “Abuse and Misuse Deterrent Transdermal Systems”, expanding Nutriband’s domestic IP footprint. This complements an already robust global patent portfolio, with coverage across 46 countries including key pharmaceutical markets in Europe, Japan, China, and Australia.

This isn’t just a legal win; it’s a strategic one. The patent strengthens Nutriband’s ability to protect its competitive edge in a space where innovation can be quickly replicated without proper safeguards. It also enhances the potential value of licensing opportunities with major pharmaceutical firms who could integrate Aversa into their own transdermal offerings.

A Leading Candidate in Abuse-Deterrent Pain Management

At the forefront of Nutriband’s development pipeline is AVERSA(TM) Fentanyl, a transdermal pain patch infused with its abuse-deterrent technology. Fentanyl, despite its clinical importance in treating severe pain, is notoriously prone to abuse and diversion. Patches can be extracted, chewed, or otherwise manipulated to release dangerously high doses.

AVERSA(TM) Fentanyl aims to counter these risks, positioning itself as a first-in-class solution with real potential for impact. According to analysis from Health Advances, peak U.S. sales could range between $80 million and $200 million annually, should the product reach market approval and adoption.

In an industry where safety and efficacy often pull in opposite directions, Nutriband believes it has found a middle ground. Its technology ensures that the therapeutic integrity of transdermal drugs is maintained, while minimizing the potential for dangerous misuse.

An Expanding Opportunity Amid a Persistent Crisis

The importance of solutions like Nutriband’s is amplified by the ongoing realities of the opioid crisis. While recent reports, such as a Virginia Governor’s press release highlighting falling overdose rates in specific counties, suggest progress, the nationwide picture remains troubling. Synthetic opioids continue to outpace other drug categories in overdose fatalities, and the rise of counterfeit medications only worsens the landscape.

The U.S. Food and Drug Administration has long sought innovation in this space, even launching a dedicated Innovation Challenge to spur development of devices and formulations that can prevent or treat opioid use disorder. Nutriband’s platform aligns directly with that mission, providing a product-based safeguard rather than relying solely on behavioral or systemic interventions.

What makes Aversa especially promising is its scalability. Though its initial focus is on fentanyl, the technology could theoretically be applied to any transdermal product susceptible to abuse, opening doors to future formulations in other high-risk categories.

Intellectual Property as a Growth Catalyst

In the pharmaceutical world, IP protection is more than just legal paperwork; it’s a growth engine. NTRB’s ongoing expansion of its patent estate reflects a commitment not just to innovation, but to long-term commercial viability. With patents now secured in 46 countries, the company is laying the groundwork for potential partnerships, licensing agreements, and product rollouts in multiple geographies.

This strategy offers more than just downside protection. It positions Nutriband to benefit from global tailwinds in drug safety regulation. As governments worldwide tighten oversight of high-risk medications, technologies like Aversa that preemptively reduce risk may gain regulatory and market preference.

For more information, visit the company’s website at www.Nutriband.com.

NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company’s newsroom at https://ibn.fm/NTRB

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
[email protected]

MissionIR is powered by IBN

Posted in Nutriband Inc. NTRB | Leave a comment